Intrinsiqq
Raphael Pharmaceutical Inc. logo

Raphael Pharmaceutical Inc. Financials

RAPH

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 5 of 6 available years
Income Statement
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
111717:1 split
General & Administrative$1$1$1$2$1
Research & Development$1$1$1$1$1
Operating Income-$1-$2-$1-$3-$2
Other Non-Operating Income (Expense)-$0-$0-$0-$0$0
Net Income
Net Income-$1-$2-$1-$3-$2
EPS (Basic)$0.07$0.08$0.08$0.23$0.15
EPS (Diluted)$0.07$0.08$0.08$0.23$0.15
Weighted Avg Shares (Basic)19.6M18.7M16.7M14.3M11.2M
Weighted Avg Shares (Diluted)19.6M18.7M16.7M14.3M11.2M
Shares Outstanding19.6M18.7M16.7M14.3M11.2M

Raphael Pharmaceutical (RAPH) financials: revenue, profit and margins

Raphael Pharmaceutical (RAPH) generated about n/a in revenue and -$980,000.00 in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Raphael Pharmaceutical profitable?+

Raphael Pharmaceutical reported about -$980,000.00 in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 14 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 15 Aug 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Medicinal Chemicals & Botanical Products · Pick stocks to compare with RAPH

CompareIntrinsic value
CBDYTarget Group Inc.
$0.00+22.22%8
ADIAAdia Nutrition Inc.
$0.12+0.00%43
FTLFFitLife Brands, Inc.
$6.32-5.67%74
MRMDMariMed Inc.
$0.05-4.08%35
USNAUsana Health Sciences, Inc.
$13.13-0.23%35
MTEXMannatech, Incorporated
$2.56+4.49%24
AAWHAscend Wellness Holdings, Inc.
$0.32-3.99%27
TCRGCannaisseur Group Inc.
No recent price0

Spot a number that looks wrong? Check it in RAPH's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing RAPH

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.